Arthur D. Levinson
description: American businessman and former CEO of Genentech, currently chairman of Apple Inc.
4 results
Immortality, Inc.
by Chip Walter · 7 Jan 2020 · 232pp · 72,483 words
the company put it, “one of life’s great mysteries.” Google? Now that was worth looking into. And just as intriguing was the news that Arthur D. Levinson had been asked to lead the company. Most people wouldn’t have known Levinson if they tripped over him, but he was a force in
…
make it a reality. And that was why Levinson was important. Truthfully, Maris hadn’t thought he had a chance in hell of getting to Arthur D. Levinson, chair of Apple Inc., and CEO and chair of Genentech, the world’s first biotechnology company. Blake Byers, a Google Ventures colleague and biomedical engineer
Troublemakers: Silicon Valley's Coming of Age
by Leslie Berlin · 7 Nov 2017 · 615pp · 168,775 words
even to consider commercial possibilities for his scientific work made him unusual in 1976. Most biologists at the time were suspicious of the corporate world. Arthur D. Levinson, who would eventually serve as CEO of Genentech and a director of both Apple and Google, recalls that as a young biochemist, if he wanted
…
the ironies here is he devoted so much of his life to applying this technology to generate medical breakthroughs, drugs that saved countless lives,” says Arthur D. Levinson, a former CEO of Genentech and director of Google and Apple, where he also chairs the board. “But unfortunately, his wasn’t one of them
…
‘Publishers’ in Computer Software,” Venture, September 1980: 79. 8. “Many of us had no idea what it meant to ‘go public.’ ” David V. Goeddel and Arthur D. Levinson, “Obituary: Robert A. Swanson (1947–99),” Nature 403 (Jan. 20, 2000): 264. 9. Burt McMurtry to author, Sept. 20, 2015. 10. Kurtzig, CEO: 187–8
…
. Andrew Pollack, “Robert A. Swanson Dies at 52; Early Leader in Biotechnology,” New York Times, Dec. 8, 1999. 21. Ibid. 22. David V. Goeddel and Arthur D. Levinson, “Obituary: Robert A. Swanson (1947–99),” Nature 403 (Jan. 20, 2000): 264. 23. Andrew Pollack, “Roche Agrees to Buy Genentech,” New York Times, March 12
Virtual Competition
by Ariel Ezrachi and Maurice E. Stucke · 30 Nov 2016
.ftc.gov/news-events/press-releases/2009/08/statement-bureau -competition-director-richard-feinstein-regarding; “Statement of FTC Chairman Jon Leibowitz Regarding the Announcement That Arthur D. Levinson Has Resigned from Google’s Board,” FTC Press Release (October 12, 2009), https://www.ftc.gov/news-events/press-releases/2009/10 /statement-ftc-chairman
The Cancer Chronicles: Unlocking Medicine's Deepest Mystery
by George Johnson · 26 Aug 2013 · 465pp · 103,303 words
the benefits, revoked approval for Avastin as a treatment for metastatic breast cancer. Such grim realities seemed far away at the grand opening session, where Arthur D. Levinson, a pioneer in the design of targeted therapies, was honored for “leadership and extraordinary achievements in cancer research.” He was cited specifically for his role